What are the benefits of UFE?
Patients who undergo uterine fibroid embolization typically notice decreased bleeding, pelvic pain and pressure, and other symptoms of uterine fibroids, as well as an overall significant improvement in physical and emotional well-being.
Who cannot go for a UFE?
Patients who have cervical, endometrial, or uterine cancer. Women with an active, recent, or chronic pelvic infection.
Who can go for a UFE?
They are experiencing uterine fibroid symptoms, including abnormal and heavy bleeding, pain during sex, pelvic pain and pressure, constipation, urinary issues, and erratic menstrual cycles.
What is uterine fibroid embolization?
Uterine artery embolization is a procedure in which an interventional radiologist uses a catheter to deliver small particles that block the blood supply to the uterine body.
What are the symptoms of uterine fibroids?
Symptoms include heavy menstrual bleeding, prolonged periods and pelvic pain. In some cases, there are no symptoms.
What are uterine fibroids?
Non-cancerous growths in the uterus that can develop during a woman's childbearing years. The cause of fibroids isn't well understood. Risk factors include a family history of fibroids, obesity or early onset of puberty.
Does insurance cover CAE?
Yes. Most insurance carriers cover CAE. Please check with your insurance provider to see if your specific plan covers the procedure.
How soon after the treatment will my symptoms improve?
Symptoms are caused by the diseased superficial vein. Thus, symptoms may improve as soon as the diseased vein is closed. Almost all patients report a noticeable improvement in at least 1-2 weeks following the procedure.
How are radiofrequency ablation and CAE different?
During vein stripping, incisions are made in the groin and calf, and a tool is threaded through the diseased vein to pull it out of the leg. With endovenous ablation or CAE, only one small incision is made at the catheter insertion site and the vein is treated and left in place.
What is the success rate of CAE procedure?
Published clinical studies show that CAE has an initial success rate of between 94% and 98.9% (6 months post treatment) with excellent long-term results. (The eScope study showed closure rate of 94.3% at 6 months and 92.9% at 12 months. The VeClose study showed closure rate of 98.9% at 6 months)
